Murano Global B.V [MRNOW] vs Amrep [AXR] Detailed Stock Comparison
Murano Global B.V
NASDAQ
Loading...
Amrep
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Murano Global B.V wins in 6 metrics, Amrep wins in 8 metrics, with 0 ties. Amrep appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Murano Global B.V | Amrep | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 9.59 | N/A |
| Price-to-Book Ratio | 0.00 | 0.93 | Murano Global B.V |
| Debt-to-Equity Ratio | 201.38 | 0.02 | Amrep |
| PEG Ratio | N/A | 0.67 | N/A |
| EV/EBITDA | -8.77 | 5.68 | Murano Global B.V |
| Profit Margin (TTM) | -223.73% | 27.54% | Amrep |
| Operating Margin (TTM) | -43.45% | 34.43% | Amrep |
| EBITDA Margin (TTM) | N/A | 34.43% | N/A |
| Return on Equity | -42.70% | 10.39% | Amrep |
| Return on Assets (TTM) | -1.88% | 6.19% | Amrep |
| Free Cash Flow (TTM) | $-77.53M | $9.66M | Amrep |
| 1-Year Return | -41.18% | -20.07% | Amrep |
| Price-to-Sales Ratio (TTM) | 0.00 | 2.61 | Murano Global B.V |
| Enterprise Value | $565.79M | $76.49M | Murano Global B.V |
| EV/Revenue Ratio | 14.26 | 1.58 | Amrep |
| Gross Profit Margin (TTM) | 80.17% | 44.78% | Murano Global B.V |
| Revenue per Share (TTM) | $9 | $9 | Murano Global B.V |
| Earnings per Share (Diluted) | N/A | $2.48 | N/A |
| Beta (Stock Volatility) | N/A | 1.27 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Murano Global B.V vs Amrep Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Murano Global B.V | 2.95% | -37.50% | -52.38% | -62.96% | -52.38% | -60.00% |
| Amrep | -0.85% | -3.38% | 9.02% | 3.49% | 26.14% | -24.40% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Murano Global B.V | -41.18% | -9.09% | -9.09% | -9.09% | -9.09% | -9.09% |
| Amrep | -20.07% | 104.98% | 264.70% | 405.39% | 114.16% | -12.24% |
Performance & Financial Health Analysis: Murano Global B.V vs Amrep
| Metric | MRNOW | AXR |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $130.78M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 13,812 | 8,360 |
| 90 Day Avg. Volume | 12,224 | 12,723 |
| Last Close | $0.10 | $23.25 |
| 52 Week Range | $0.09 - $0.42 | $17.60 - $39.67 |
| % from 52W High | -75.75% | -41.39% |
| All-Time High | $0.42 (Feb 24, 2025) | $149.99 (Jan 15, 2007) |
| % from All-Time High | -76.19% | -84.50% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 4.08% | -0.07% |
| Quarterly Earnings Growth | -0.84% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | -2.24% | 0.28% |
| Operating Margin (TTM) | -0.43% | 0.34% |
| Return on Equity (TTM) | -0.43% | 0.10% |
| Debt to Equity (MRQ) | 201.38 | 0.02 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $65.65 | $25.56 |
| Cash per Share (MRQ) | $4.45 | $9.28 |
| Operating Cash Flow (TTM) | $-3,336,251 | $9.08M |
| Levered Free Cash Flow (TTM) | $-81,448,023 | $4.99M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Murano Global B.V vs Amrep
| Metric | MRNOW | AXR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 9.59 |
| Forward P/E | N/A | 12.46 |
| PEG Ratio | N/A | 0.67 |
| Price to Sales (TTM) | 0.00 | 2.61 |
| Price to Book (MRQ) | 0.00 | 0.93 |
| Market Capitalization | ||
| Market Capitalization | $0 | $130.78M |
| Enterprise Value | $565.79M | $76.49M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.26 | 1.58 |
| Enterprise to EBITDA | -8.77 | 5.68 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.27 |
| Book Value per Share (MRQ) | $65.65 | $25.56 |
Financial Statements Comparison: Murano Global B.V vs Amrep
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRNOW | AXR |
|---|---|---|
| Revenue/Sales | $17.43M | $17.85M |
| Cost of Goods Sold | $3.46M | $9.86M |
| Gross Profit | $13.97M | $7.99M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-3.49M | $6.15M |
| EBITDA | $1.39M | $6.22M |
| Pre-Tax Income | $-19.51M | $6.60M |
| Income Tax | $-2.27M | $1.91M |
| Net Income (Profit) | $-17.24M | $4.69M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRNOW | AXR |
|---|---|---|
| Cash & Equivalents | $25.49M | $39.47M |
| Total Current Assets | $55.01M | $107.46M |
| Total Current Liabilities | $222.57M | $3.79M |
| Long-Term Debt | $424.27M | $26,000 |
| Total Shareholders Equity | $276.97M | $129.96M |
| Retained Earnings | $-225.59M | $96.02M |
| Property, Plant & Equipment | $11.47M | $2.63M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRNOW | AXR |
|---|---|---|
| Operating Cash Flow | $3.40M | $4.79M |
| Capital Expenditures | $-7.77M | $0 |
| Free Cash Flow | $-6.38M | $2.53M |
| Debt Repayment | $-6.86M | $-2,000 |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MRNOW | AXR |
|---|---|---|
| Shares Short | N/A | 24,803 |
| Short Ratio | N/A | 2.20 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 13,812 | 8,360 |
| Average Daily Volume (90 Day) | 12,224 | 12,723 |
| Shares Outstanding | 4.31M | 5.29M |
| Float Shares | 1.35M | 2.87M |
| % Held by Insiders | N/A | 0.45% |
| % Held by Institutions | N/A | 0.45% |
Dividend Analysis & Yield Comparison: Murano Global B.V vs Amrep
| Metric | MRNOW | AXR |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |